EMD Serono, Merck KGaA’s U.S. and Canada-based biopharmaceutical business, recently received Food and Drug Administration approval for a redesigned version of a pen injector, designed to be used to induce ovulation and pregnancy in certain oligo-anovulatory women.
To boost support for caregivers on an international scale, Merck KGaA of Darmstadt, Germany, launched a worldwide program called Embracing Carers and presented recent survey results at a conference in Australia.
The approval late last month of Bavencio, a treatment for an unusual and aggressive form of skin cancer, relied on two Food and Drug Administration programs designed to expedite drug review and usher them to the market faster.
EMD Serono, a biopharmaceutical business operating under Merck KGaA in Darmstadt, Germany, recently announced that it has received CEO Cancer Gold Standard re-accreditation for its dedication to employee health.
Merck KGaA in Darmstadt, Germany, recently welcomed Hamilton Thorne and ZEISS as the two most recent members of the company’s Global Fertility Alliance, which already includes Illumina, Genea and Merck KGaA.